GAMMA Investing’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
8,996
+2,410
+37% +$56.3K 0.01% 1090
2026
Q1
$126K Buy
6,586
+3,207
+95% +$70.9K 0.01% 1494
2025
Q4
$81.7K Buy
3,379
+130
+4% +$3.4K ﹤0.01% 1721
2025
Q3
$82.9K Sell
3,249
-268
-8% -$6.36K ﹤0.01% 1639
2025
Q2
$75.8K Sell
3,517
-706
-17% -$15.9K ﹤0.01% 1634
2025
Q1
$96.5K Buy
4,223
+663
+19% +$17.5K 0.01% 1286
2024
Q4
$92.4K Buy
3,560
+265
+8% +$6.59K 0.01% 1173
2024
Q3
$82.5K Buy
3,295
+748
+29% +$17.7K 0.01% 1130
2024
Q2
$54.6K Sell
2,547
-112
-4% -$2.17K 0.01% 1130
2024
Q1
$49.3K Buy
2,659
+265
+11% +$4.63K 0.01% 1056
2023
Q4
$40.7K Buy
+2,394
New +$30.5K 0.01% 1021

Other funds holding BLFS

GAMMA Investing's BLFS Position: Q2 2026 in Review

GAMMA Investing increased its BioLife Solutions (BLFS) stake by 37% in Q2 2026, buying an estimated $56.3K and bringing the position to 8,996 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #1090.

GAMMA Investing first reported a position in BLFS in Q4 2023 and has held it in 11 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • GAMMA Investing held 8,996 shares of BioLife Solutions worth $254K as of Q2 2026.
  • GAMMA Investing bought 2,410 BioLife Solutions shares in Q2 2026, an estimated $56.3K.
  • BioLife Solutions made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1090 holding.
  • GAMMA Investing first reported a position in BioLife Solutions in Q4 2023 and has held it in 11 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.